Med Inc.

Behind the media headlines that chronicle the successes--as well asthe charges of fraud, abuse, and ethical misconduct--of today'scorporate medical giants lies the story of the Wall Street playerswho are determining the structure of our future health systems.Independent hospitals and clinics, small medical technologycompanies, solo practitioners, and consumers alike acknowledge thatthe big business
principles driving the frenzy of mergers and acquisitions arebringing the long-awaited rewards of accountability andpredictability to the fragmented healthcare industry. But at whatcost?

Sandy Lutz, a renowned medical business reporter and investmentanalyst, and Big Six accounting firm partners Woodrin Grossman andJohn Bigalke provide their insiders' insights into the financialworkings of Wall Street's mighty medical corporations--a class theauthors refer to as Med Incorporated. With an in-depth study of themost notable leader, Columbia/HCA Healthcare Corp., plusillustrative examples of other medical giants, Lutz and hercoauthors demonstrate how these Med Inc. companies excel inmanaging capital, information, risk, and government regulation--thefour key success factors to achieving operational efficiency andmarket dominance. They show how the missions and operations ofinvestor-owned companies compare with their noninvestor-ownedcounterparts and examine how current technological and marketdevelopments will shape the future of health systems.

“"This book is a valuable resource for anyone interested in learningmore about one of the major trends impacting the health caresystem." (Doody's Publishing Services) "Well written. Med Inc. leaves readers with a taste of what's tocome--and a warning that bigger is not always better."”

"This book is a valuable resource for anyone interested in learningmore about one of the major trends impacting the health caresystem." (Doody's Publishing Services)

"Well written. Med Inc. leaves readers with a taste of what's tocome--and a warning that bigger is not always better."

SANDY LUTZ a medical business writer, author, speaker, and media commentator, is a healthcare analyst at Rauscher Pierce Refsnes, a Dallas-based investment bank. She has chronicled the business of health care for such respected national media as Modern Healthcare and WestCott Communications, the nation's largest healthcare satellite network, and in her first book, The For-Profit Healthcare Revolution (1995). JOHN BIGALKE, partners at Price Waterhouse, a Big Six accounting firm, have served as trusted financial advisors to some of the country's largest medical companies on issues ranging from going public to fraud problems to strategy development.

Behind the media headlines that chronicle the successes—as well as the charges of fraud, abuse, and ethical misconduct—of todays corporate medical giants, lies the story of the Wall Street players who are determining the structure of our future health systems. Independent hospitals and clinics, small medical technology companies, solo practitioners, and consumers alike acknowledge that the "big business" principles driving the frenzy of mergers and acquisitions are bringing the long-awaited rewards of accountability and predictability to the fragmented healthcare industry. But at what cost?

Sandy Lutz, a renowned medical business reporter and investment analyst, and Big Six accounting firm partners Woodrin Grossman and John Bigalke provide their insiders insights into the financial workings of Wall Streets mighty medical corporations—a class the authors refer to as Med Incorporated. With an in-depth study of the most notable leader, Columbia/HCA Healthcare Corp., plus illustrative examples of several other medical giants, Lutz and her coauthors demonstrate how these Med Inc. companies excel in managing capital, information, risk, and government regulation—the four key success factors to achieving operational efficiency and market dominance. They show how the missions and operations of investor-owned companies compare with their noninvestor owned counterparts, and examine how current technological and market developments will shape the future of health systems.

For healthcare executives, analysts, investors, and the Med Incorporated companies of tomorrow, Med Inc. offers a behind-the-scenes look at what it takes to participate successfully in the developing investor-owned organizations that are destined to define the national health system well into the 21st century.

Behind the media headlines that chronicle the successes as well as the charges of fraud, abuse, and ethical misconduct of today's corporate medical giants, lies the story of the Wall Street players who are determining the structure of our future health systems. Independent hospitals and clinics, small medical technology companies, solo practitioners, and consumers alike acknowledge that the "big business" principles driving the frenzy of mergers and acquisitions are bringing the long-awaited rewards of accountability and predictability to the fragmented healthcare industry. But at what cost? Sandy Lutz, a renowned medical business reporter and investment analyst, and Big Six accounting firm partners Woodrin Grossman and John Bigalke provide their insiders? insights into the financial workings of Wall Street's mighty medical corporations a class the authors refer to as Med Incorporated. With an in-depth study of the most notable leader, Columbia/HCA Healthcare Corp., plus illustrative examples of several other medical giants, Lutz and her coauthors demonstrate how these Med Inc. companies excel in managing capital, information, risk, and government regulation the four key success factors to achieving operational efficiency and market dominance. They show how the missions and operations of investor-owned companies compare with their noninvestor owned counterparts, and examine how current technological and market developments will shape the future of health systems. For healthcare executives, analysts, investors, and the Med Incorporated companies of tomorrow, Med Inc. offers a behind-the-scenes look at what it takes to participate successfully in the developing investor-owned organizations that are destined to define the national health system well into the 21st century.

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.